Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Histiocytosis X.

B E Favara, R C McCarthy, G W Mierau

    Human Pathology
    |August 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Histiocytosis X, encompassing Letterer-Siwe disease and eosinophilic granuloma, requires further research. Current understanding of its pathogenesis and effective therapies for disseminated forms remains limited, necessitating advanced immunologic and genetic studies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Histiocytosis Syndromes Classification, Diagnostic Features and Current Concepts.

    Leukemia & lymphoma·2016
    Same author

    Characterization and functional assessment of Clostridium histolyticum class I (C1) collagenases and the synergistic degradation of native collagen in enzyme mixtures containing class II (C2) collagenase.

    Transplantation proceedings·2011
    Same author

    Tissue dissociation enzyme neutral protease assessment.

    Transplantation proceedings·2010
    Same author

    Development and characterization of a collagen degradation assay to assess purified collagenase used in islet isolation.

    Transplantation proceedings·2008
    Same author

    Amylopectinosis disease isolated to the heart with normal glycogen branching enzyme activity and gene sequence.

    Pediatric transplantation·2005
    Same author

    Choroid plexus carcinomas and rhabdoid tumors: phenotypic and genotypic overlap.

    Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2002
    Same journal

    TRPS1 and GATA3 Expression in BRG1/SMARCA4-deficient Malignant Neoplasms.

    Human pathology·2026
    Same journal

    Clinicopathologic and Molecular Characteristics of Acral Melanomas Harboring RARA Fusions.

    Human pathology·2026
    Same journal

    Clinical Impact of Second Opinion Consultation in Bladder Biopsies and Transurethral Resection of Bladder Tumors.

    Human pathology·2026
    Same journal

    Prognostic relevance and molecular correlates of Claudin-1 expression in pancreatic neuroendocrine tumors.

    Human pathology·2026
    Same journal

    Mixed Phenotype Acute Leukemia: Lineage Assignment, Immunophenotypic Classification and Genetic Insights.

    Human pathology·2026
    Same journal

    Chronic myelomonocytic leukemia revisited: A comprehensive review with emphasis on the oligomonocytic subtype.

    Human pathology·2026
    See all related articles

    Area of Science:

    • Pathology
    • Immunology
    • Genetics

    Background:

    • Histiocytosis X is a syndrome including Letterer-Siwe disease, Hand-Schuller-Christian disease, and eosinophilic granuloma.
    • Histiocytes and Langerhans cells are key cellular components in active lesions.
    • The pathogenesis of Histiocytosis X remains incompletely understood.

    Purpose of the Study:

    • To review epidemiologic data, and diagnostic and prognostic bases for Histiocytosis X.
    • To characterize Langerhans cells in active lesions.
    • To propose pathogenetic schemas for future investigation.

    Main Methods:

    • Review of existing epidemiologic data.
    • Analysis of histologic, morphologic, and clinical findings.
    • Characterization of Langerhans cells.

    Related Experiment Videos

    Main Results:

    • Histiocytosis X encompasses several distinct clinical presentations.
    • Langerhans cells are identified as a significant component of active lesions.
    • Current therapies for disseminated Histiocytosis X are not proven effective.

    Conclusions:

    • Histiocytosis X requires further investigation into its pathogenesis.
    • Immunologic and genetic studies are recommended to test proposed pathogenetic schemas.
    • Disseminated Histiocytosis X remains an unpredictable disease with no established effective therapy.